Effectiveness of local anesthetic in controlling abdominal pain in laparoscopic gynecological surgery.
Phase 1
- Conditions
- EFECTIVENESS OF ROPIVACAINE 0,1% FOR PAIN CONTROL AFTER LAPAROSCOPIC GYNECOLOGICAL SURGERYTherapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
- Registration Number
- EUCTR2014-002309-39-ES
- Lead Sponsor
- Osakidetza
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
FEMALES WHO NEED A GYNECOLOGY LAPAROSCOPIC SURGERY FOR BENING DISEASES
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 60
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 14
Exclusion Criteria
REFUSE TO PARTICIPATE IN THE TRIAL. OVER 2 HOUR OF SURGERY AND ALLERGY TO ANY MEDICATION THAT IT IS USED.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: EXTENT OF POSTOPERATIVE PAIN;Secondary Objective: NAUSEA AND VOMITING<br>EARLY MOBILIZATION<br>PAIN AT SEVENTH DAY;Primary end point(s): VISUAL ANALOGIC SCALE;Timepoint(s) of evaluation of this end point: INMEDIATE POSTOPERATIVE, AT 2,12 AND 24 HOURS
- Secondary Outcome Measures
Name Time Method Secondary end point(s): MEDICAL HISTORY;Timepoint(s) of evaluation of this end point: INMEDIATE POSTOPERATIVE, AT 2,12 AND 24 HOURS